Corium (CORI) Alert: Johnson Fistel Investigates Proposed Sale of Corium International, Inc. to Gurnet Point Capital; Are Shareholders Getting a Fair Deal?
SAN DIEGO, Oct. 12, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Corium International, Inc. ("Corium") (NASDAQ: CORI) breached their fiduciary duties in connection with the proposed sale of the Company to Gurnet Point Capital ("Gurnet").
On October 11, 2018, Corium announced that it had signed a definitive merger agreement with Gurnet. Under the terms of the merger agreement, Gurnet will pay $12.50 per share in cash upon the closing. The agreement also provides for a Contingent Value Right of $0.50 per share that is payable based on the FDA's approval of Corium's lead product candidate, Corplex Donepezil, for the treatment of Alzheimer's disease, prior to March 31, 2020.
The investigation concerns whether the Corium board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Corium shares of common stock.
If you are a shareholder of Corium and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471. If emailing, please include a phone number.
Additionally, you can [click here to join this action].There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]
[click here to join this action]
SOURCE Johnson Fistel, LLP
News published on and distributed by:
